Second-trimester Abortion.
Journal
Clinical obstetrics and gynecology
ISSN: 1532-5520
Titre abrégé: Clin Obstet Gynecol
Pays: United States
ID NLM: 0070014
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
medline:
16
11
2023
pubmed:
1
11
2023
entrez:
1
11
2023
Statut:
ppublish
Résumé
In 2019, the US Centers for Disease Control reported that 7% of abortions were performed after 13 weeks of pregnancy, a small proportion of all terminations. However, the need for second-trimester abortions will increase commensurate with restrictions to access nationwide. Second-trimester abortions are performed with medications or through a procedure. Health care practitioners serving persons at risk of pregnancy should understand how abortions are performed and how to deliver evidence-based postabortion care. The purpose of this article is to provide a foundation for caring for individuals before, during, and after second-trimester abortion.
Identifiants
pubmed: 37910075
doi: 10.1097/GRF.0000000000000825
pii: 00003081-990000000-00114
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
685-697Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Kortsmit K, Nguyen AT, Mandel MG, et al. Abortion surveillance—United States, 2020. MMWR Surveill Summ. 2022;71(SS-10):1–27.
American College of Obstetricians and Gynecologists Second-trimester abortion. ACOG Practice Bulletin No. 135. Obstet Gynecol. 2013;121:1394–1406.
Foster DG, Biggs MA, Ralph L, et al. Socioeconomic outcomes of women who receive and women who are denied wanted abortions in the Untied States. Am J Public Health. 2018;108:407–413.
Guttmacher Institute Bans on specific abortion methods used after the first trimester. Accessed June 1, 2023. https://www.guttmacher.org/state-policy/explore/bans-specific-abortion-methods-used-after-first-trimester
Roberts SCM, Upadhyay UD, Liu G, et al. Association of facility type with procedural-related morbidities and adverse events among patients undergoing induced abortions. JAMA. 2018;319:2497–2506.
Chasen ST, Kalish RB, Gupta M, et al. Dilation and evacuation at ≥20 weeks: comparison of operative techniques. Am J Obstet Gynecol. 2004;190:1180–1183.
Autry AM, Hayes EC, Jacobson GF, et al. A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol. 2002;187:393–397.
Bryant AG, Grimes DA, Garrett JM, et al. Second-trimester abortion for fetal anomalies or fetal death: labor induction compared with dilation and evacuation. Obstet Gynecol. 2011;117:788–792.
Sonalkar S, Ogden SN, Tran LK, et al. Comparison of complications associated with induction by misoprostol versus dilation and evacuation for second-trimester abortion. Int J Gynecol Obstet. 2017;138:272–275.
Kerns J, Steinauer J. Management of postabortion hemorrhage. Contraception. 2013;87:331–342.
Kerns JL, Ti A, Aksel S, et al. Disseminated intravascular coagulation and hemorrhage after dilation and evacuation abortion for fetal death. Obstet Gynecol. 2019;134:708–713.
O’Connell K, Jones HE, Simon M, et al. First-trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception. 2009;79:385–392.
Kim R, Pelletier A, Donnenfeld B, et al. Safety of deep sedation without intubation during surgical abortion in the independent clinic setting. Contraception. 2020;101:298–301.
Achilles SL, Reeves MF. Prevention of infection after induced abortion. Contraception. 2011;83:295–309.
Edelman A, Kapp N. Dilation and Evacuation (D&E) Reference Guide: Induced Abortion and Postabortion Care at or after 13 Weeks Gestation (‘second Trimester’). IPAS; 2018.
Grossman D, Blanchard K, Blumenthal P. Complications after second trimester surgical and medical abortion. Reprod Health Matters. 2008;16:173–182.
Lichtenberg ES. Complications of osmotic dilators. Obstet Gynecol Surv. 2004;59:528–536.
Fox MC, Krajewski CM. Cervical preparation for second-trimester surgical abortion prior to 20 weeks’ gestation. Contraception. 2014;89:75–84.
Diedrich JT, Drey EA, Newmann SJ. Society of Family Planning clinical recommendations: cervical preparation for dilation and evacuation at 20–24 weeks’ gestation. Contraception. 2020;101:286–292.
Fraz F, Hou MY. Mechanical dilation to remove incarcerated laminaria during a second trimester abortion. Contraception. 2021;103:284–286.
Soon R, Tschann M, Salcedo J, et al. Paracervical block for laminaria insertion before second-trimester abortion: a randomized controlled trial. Obstet Gynecol. 2017;130:387–392.
Allanson ER, Copson S, Spilsbury K. Pretreatment with mifepristone compared with misoprostol alone for delivery after fetal death between 14 and 28 weeks of gestation: a randomized controlled trial. Obstet Gynecol. 2021;137:801–809.
Perritt JB, Burke A, Edelman AB. Interruption of nonviable pregnancies of 24–28 weeks’ gestation using medical methods. Contraception. 2013;88:341–349.
Wingo E, Raifman S, Landau C, et al. Mifepristone–misoprostol versus misoprostol-alone regimen for medication abortion at ≥24 weeks’ gestation. Contraception. 2020;102:99–103.
Borgatta L, Kapp N. Labor induction abortion in the second trimester. Contraception. 2011;84:4–18.
Hammond C, Chasen S. Dilation and evacuation. Management of Unintended and Abnormal Pregnancy. John Wiley & Sons, Ltd; 2009:157–177.
Schulz KF, Grimes DA, Christensen DD. Vasopressin reduces blood loss from second-trimester dilatation and evacuation abortion. The Lancet. 1985;326:353–356.
Frick AC, Drey EA, Diedrich JT, et al. Effect of prior cesarean delivery on risk of second-trimester surgical abortion complications. Obstet Gynecol, 115:760–764.
Whitehouse K, Tschann M, Soon R, et al. Effects of prophylactic oxytocin on bleeding outcomes in women undergoing dilation and evacuation: a randomized controlled trial. Obstet Gynecol. 2019;133:484–491.
Grimes DA, Flock ML, Schulz KF, et al. Hysterectomy as treatment for complications of legal abortion. Obstet Gynecol. 1984;63:457–462.
Creinin MD, Blumenthal P, Shulman L. Mifepristone-misoprostol medical abortion mortality. Medscape Gen Med. 2006;8:26.
Elimian A, Verma U, Tejani N. Effect of causing fetal cardiac asystole on second-trimester abortion. Obstet Gynecol. 1999;94:139–141.
Jackson R, Teplin V, Drey E, et al. Digoxin to facilitate late second-trimester abortion: a randomized, masked, placebo-controlled trial. Obstet Gynecol. 2001;97:471–476.
Lee SJ, Ralston HJP, Drey EA, et al. Fetal pain—a systematic multidisciplinary review of the evidence. JAMA. 2005;294:947–954.
Molaei M, Jones HE, Weiselberg T, et al. Effectiveness and safety of digoxin to induce fetal demise prior to second-trimester abortion. Contraception. 2008;77:223–225.
Pasquini L, Pontello V, Kumar S. Intracardiac injection of potassium chloride as method for feticide: experience from a single UK tertiary centre. BJOG Int J Obstet Gynaecol. 2008;115:528–531.
Hern W. Laminaria, induced fetal demise and misoprostol in late abortion. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2002;75:279–286.
Mui SVLK, Chitrit Y, Boulanger MC, et al. Sepsis due to Clostridium perfringens after pregnancy termination with feticide by cordocentesis: a case report. Fetal Diagn Ther. 2002;17:124–126.
World Health Organization Abortion care guideline. 2022. https://www.who.int/publications/i/item/9789240039483
Henkel A, Johnson S, Cahill E, et al. Cabergoline for lactation inhibition after second-trimester abortion or loss: a randomized controlled trial. Contraception. 2022;116:70.
Prine LW, MacNaughton H. Office management of early pregnancy loss. Am Fam Physician. 2011;84:75–82.
Hu A. Reflections: the value of patient support groups. Otolaryngol Neck Surg. 2017;156:587–588.
Jones RK, Kirstein M, Philbin J. Abortion incidence and service availability in the United States, 2020. Perspect Sex Reprod Health. 2022;54:128–141.
Guttmacher Institute Induced abortion in the United States. Guttmacher Institute. Accessed September 3, 2023. https://www.guttmacher.org/fact-sheet/induced-abortion-united-states